Product information

Current status:

Cancelled Post Market

Current status date:

2004-01-02

Original market date: ^{See footnote 1}

1998-10-13

Product name:

ONCASPAR

DIN:

02236849 Electronic product monograph is not available

Company:

AVENTIS PHARMA INC
2905 Place Louis-R. Renaud
Laval
Quebec
Canada H7V 0A3

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intramuscular ,  Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription ,  Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

10:00.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

L01XX24 PEGASPARGASE

Active ingredient group (AIG) number:^{See footnote5}

0131872001

Risk Management Plans ^{See footnote 7}

A Risk Management Plan (RMP) for this product was submitted.